Employment of cytology for in vitro skin irritation test using a reconstructed human epidermis model, Keraskin™.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 08 04 2020
revised: 03 07 2020
accepted: 27 07 2020
pubmed: 12 8 2020
medline: 10 8 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Skin irritation tests using reconstructed human epidermis (RhE) employ viability as an endpoint, but color interference or borderline results are often problematic. We examined whether the cytology of cells from treated RhE could determine skin irritancy. Six chemicals (three irritants; DnP, 1-B, PH, three non-irritants; DP, APA, HS) were evaluated in a RhE, Keraskin™. DP, HS, and PH were clearly classified with viability, but DnP, 1-B, and APA were often falsely determined, due to borderline values falling near the cutoff, 50%. In histology, the tissues treated with DnP, 1-B, and PH showed erosion of the stratum corneum, vacuolization, and necrosis in the basal layer. DP- and HS-treated tissues showed relatively normal morphology but APA induced necrosis similar to irritants. Cytology revealed that DnP, 1-B or PH depleted cells and induced irregular and abnormal cell shapes. In contrast, relatively regular and normal shapes and clear distinction between the nucleus and cytoplasm was observed for DP, APA and HS. To further confirm it, additional 10 substances, including false positives from OECD TG 439, were tested. Overall (16 substances in total), cytology: total area predicted the skin irritancy of test chemicals with the highest accuracy (87.5%) followed by cytology: cell count (81.3%), histology (75%) and viability (68.8%), confirming the utility of cytology as an alternative endpoint in the skin irritation test using RhE.

Identifiants

pubmed: 32781017
pii: S0887-2333(20)30512-9
doi: 10.1016/j.tiv.2020.104962
pii:
doi:

Substances chimiques

Disulfides 0
Glycolates 0
Hydrocarbons, Halogenated 0
Hydroxides 0
Irritants 0
Phthalic Acids 0
Potassium Compounds 0
Salicylates 0
hexyl salicylate 8F78EY72YL
n-propyl disulfide I7K169J70F
allyl phenoxyacetate Q3P8UAF9WE
diethyl phthalate UF064M00AF
1-bromohexane WVA0FAX7GA
potassium hydroxide WZH3C48M4T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104962

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there are no conflicts of interest.

Auteurs

Jee-Hyun Hwang (JH)

College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.

Haengdueng Jeong (H)

College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.

Sumin Hur (S)

College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.

Ki Taek Nam (KT)

College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.

Kyung-Min Lim (KM)

College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH